regulations

A groundbreaking study shows great promise for children with diabetes, DMT research for stroke patients awaits approval and China tightens anti-monopoly laws

Dr Carlos Camozzi is the new Chief Medical Officer at the Biotech Company Orphazyme, located in Denmark. Carlos has over 25 years in clinical research and development roles in pharma and biotech com...

Agile methodologies implemented into software development projects in healthcare are fast becoming more  popular, but how can you achieve a successful agile project from conception to comp...

Increased complexity of clinical trials, entering into new regions, multiple site trials and differing regulatory requirements are all adding to the difficulties of getting the right supplies to t...

Dr. Hans-Georg Eichler, Senior Medical Officer for the European Medicines Agency, talks to Andrea Charles from Pharma IQ, abut the Agency's growth, starting a common language between p...

According to Transparency International's Bribe Payers Index, among 19 industry sectors globally, life sciences is perceived to be the 6th most corrupt sector, in terms of the propensity of compa...

The increasing complexity and globalization of clinical trials has changed the pre-market environment, with more companies outsourcing operations and investigating emerging markets. Pharma IQ hosted...

The increasing complexity and globalization of clinical trials has changed the pre-market environment, with more companies outsourcing operations and investigating emerging markets. This leads to qu...

Dr. Nasser Al-Qahtani, Head, Adverse Drug Reactions Evaluations Department, Saudi FDA, joins Pharma IQ to discuss the Saudi FDA’s pharmacovigilance system and what new guidelines he predicts will be a...